Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Jacob N Beverage"'
Publikováno v:
PLoS ONE, Vol 17, Iss 1, p e0261336 (2022)
Subcutaneous (SC) administration of rituximab provides an opportunity for reduced patient treatment burden and increased healthcare efficiencies as an alternative to intravenous (IV) rituximab. There is minimal evidence comparing costs associated wit
Externí odkaz:
https://doaj.org/article/bc497e8f54934627933fa49233d92b93
Publikováno v:
Journal of pharmaceutical sciences. 96(9)
The cytochrome P450 2D6 (CYP2D6) is an enzyme known to metabolize a variety of xenobiotics and drugs. Inter-individual variation in the metabolic capacity of this enzyme has been extensively studied and associations with genotype have been establishe
Autor:
Jacob N. Beverage, William D. Figg
Publikováno v:
Cancer biologytherapy. 5(9)
Localized prostate cancer is a disease associated with significant biochemical recurrence with rising serum prostate-specific antigen (PSA) levels and marked progression. More specific prognostic methods are needed to identify the occult micrometasta
Autor:
Sonia Mediouni, Krishna Chinthalapudi, Mary K. Ekka, Ippei Usui, Joseph A. Jablonski, Mark A. Clementz, Guillaume Mousseau, Jason Nowak, Venkat R. Macherla, Jacob N. Beverage, Eduardo Esquenazi, Phil Baran, Ian Mitchelle S. de Vera, Douglas Kojetin, Erwann P. Loret, Kendall Nettles, Souvik Maiti, Tina Izard, Susana T. Valente
Publikováno v:
mBio, Vol 10, Iss 1 (2019)
ABSTRACT The intrinsically disordered HIV-1 Tat protein binds the viral RNA transactivation response structure (TAR), which recruits transcriptional cofactors, amplifying viral mRNA expression. Limited Tat transactivation correlates with HIV-1 latenc
Externí odkaz:
https://doaj.org/article/602de632323a423fab4a3dba4bf5eaf7